Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: Dr Goodhybe who wrote (7)	8/2/1999 12:22:00 PM
From: Doug B.	Read Replies (1) \| Respond to of 746

What is Celera's business plan? What exactly do their licensing agreements cover - i.e. how long before publication? Are they going to publish everything they generate? Certainly they are going to generate an enormous amount of sequence, and their licensing agreements will generate income, but what is the greater plan? Is their underlying goal to be an end-user testbed for new PE-Biosystems' hardware/chemistry as it is developed? Are they trying to push the envelope in speed and throughput so they can eventually sequence individual organisms (read humans)? If they could sequence a dozen people with some disorder and compare their genomes, they would likely discover the genetic basis for the disorder (if any). And they wouldn't have to publish _that_ immediately... I am a grad student in Computer Science, working on protein sequence analysis, and an investor. I know enough to see that this industry is where the microelectronics industry was in the 70's. If only we knew who the Intel was... Any thoughts from the few people who seem to be on this thread? Doug